Non-Melanoma Skin Cancer Detection in the Age of Advanced Technology: A Review
Cancers · 07.06.2023 · 15 (12) · 3094
DOI: 10.3390/cancers15123094 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 07.06.2023. Verfasst von Haleigh Stafford und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Baylor College of Medicine, Houston, TX 77030, USA. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCR NIH HHS, NIH/NIDCR, NIH/NCI.
Abstract (Originalsprache)
Skin cancer is the most common cancer diagnosis in the United States, with approximately one in five Americans expected to be diagnosed within their lifetime. Non-melanoma skin cancer is the most prevalent type of skin cancer, and as cases rise globally, physicians need reliable tools for early detection. Artificial intelligence has gained substantial interest as a decision support tool in medicine, particularly in image analysis, where deep learning has proven to be an effective tool. Because specialties such as dermatology rely primarily on visual diagnoses, deep learning could have many diagnostic applications, including the diagnosis of skin cancer. Furthermore, with the advancement of mobile smartphones and their increasingly powerful cameras, deep learning technology could also be utilized in remote skin cancer screening applications. Ultimately, the available data for the detection and diagnosis of skin cancer using deep learning technology are promising, revealing sensitivity and specificity that are not inferior to those of trained dermatologists. Work is still needed to increase the clinical use of AI-based tools, but based on the current data and the attitudes of patients and physicians, deep learning technology could be used effectively as a clinical decision-making tool in collaboration with physicians to improve diagnostic efficiency and accuracy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
- Division of Internal Medicine, Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- Graduate School of Biomedical Sciences, The University of Texas, Houston, TX 77030, USA.
- Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
ORCID-Profile: Elizabeth Chiang, Dan Yaniv
Förderung
- NIDCR NIH HHS
- NIH/NIDCR
- NIH/NCI
- University of Texas MD Anderson Cancer Center SPORE in Melanoma Jim Mulva Foundation
Zitieren
APA
Stafford, H., Buell, J., Chiang, E., Ramesh, U., Migden, M., Nagarajan, P., Amit, M., & Yaniv, D. (2023). Non-Melanoma Skin Cancer Detection in the Age of Advanced Technology: A Review. Cancers, 15(12), 3094. https://doi.org/10.3390/cancers15123094
Vancouver
Stafford H, Buell J, Chiang E, Ramesh U, Migden M, Nagarajan P, et al. Non-Melanoma Skin Cancer Detection in the Age of Advanced Technology: A Review. Cancers. 2023;15(12):3094. doi:10.3390/cancers15123094
BibTeX
@article{Stafford2023,
author = {Stafford, Haleigh and Buell, Jane and Chiang, Elizabeth and Ramesh, Uma and Migden, Michael and Nagarajan, Priyadharsini and Amit, Moran and Yaniv, Dan},
title = {Non-Melanoma Skin Cancer Detection in the Age of Advanced Technology: A Review},
journal = {Cancers},
year = {2023},
volume = {15},
number = {12},
pages = {3094},
doi = {10.3390/cancers15123094}
}
EUVIMED